Tsourdi E, Zillikens MC, Meier C, Body JJ, et al. Fracture risk and management of discontinuation of denosumab therapy: a systematic review and position statement by ECTS. J Clin Endocrinol Metab 2020 Oct 26. pii: 5939974. doi: 10.1210.
PMID: 33103722